Scientist makes astonishing discovery after observing US-Mexico border wall with motion-sensing cameras: 'Beautiful region'
Much has been reported about the border wall between Mexico and the United States. It is designed to separate the two nations and prevent people from passing between the countries unchecked.
However, a study has outlined the large and unintended consequences of the wall on nature and wildlife in the area.
What's happening?
As Vox detailed, the border wall in the southwest United States covering parts of Arizona and New Mexico also cuts through a swath of rugged natural terrain.
The area is home to a diverse ecosystem of plants and animals that have been heavily impacted by the wall.
Ganesh Marín, who was a doctoral researcher at the University of Arizona, set up 85 motion-sensor cameras in the region. The cameras captured various species, including ocelots, jaguars, beavers, and black bears. All in all, Marín ended up with about 21,000 clips.
Why is this study concerning?
The videos suggest the animals are avoiding the wall as much as possible and changing their behaviors in response. This is frustrating because the animals need to be able to wander the area freely to find water, food, and mates.
Unfortunately, this is not the only way the wall has caused a problem for local wildlife. Last year, when fires swept through parts of Texas, frogs, snakes, and other animals close to the border couldn't escape because they were blocked by a section of the border wall.
Ecosystems are already under threat because of rising global temperatures. According to the United Nations, many animals have already lost their habitats due to changing climates as well as the overdevelopment of land. The border wall only exacerbates an already growing problem.
What's being done to protect wildlife?
One way for people to fight back is to take local action in their own communities to ensure wildlife and ecosystems are protected. Another way is to vote for candidates who recognize the importance of these environmental issues, regardless of their side of the political aisle.
As Marín noted, "Amazing wildlife is present in the borderlands due to the binational efforts to protect and restore the flow of life between both countries. We should not define this beautiful region and the creatures that roam by the existence of an imposed division."
Do you think America is in a housing crisis?
Definitely
Not sure
No way
Only in some cities
Click your choice to see results and speak your mind.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
Lu177-B7H3 monoclonal antibody is first in class targeted radiopharmaceutical in development against the 4lg subtype of B7-H3 On track to initiate first-in-human study of RV-01 in solid tumors in 4Q25 SYDNEY, July 28, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, 'Radiopharm' or the 'Company'), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has provided clearance of the Company's Investigational New Drug (IND) application for Betabart (RV-01), its Lu177-B7H3 monoclonal antibody designed with strong affinity for the 4Ig isoform of B7H3 that is highly expressed in tumors and not in healthy tissues. 'FDA clearance to initiate our first-in-human Phase 1 clinical trial of RV-01 represents a major milestone for Radiopharm Theranostics and our joint venture with MD Anderson Cancer Center,' said Riccardo Canevari, CEO and Managing Director. 'RV-01 is the first monoclonal antibody developed through this collaboration, and we believe it has the potential to become a highly differentiated radiopharmaceutical for patients with aggressive solid tumors. We are excited to advance this program into the clinic and anticipate dosing the first patients later this year.' 'Recent reported preclinical studies demonstrated that RV-01 exhibits hepatic clearance, allowing the isotope sufficient time to effectively target tumors while potentially minimizing adverse effects such as hematological toxicities. Unlike peptides or small molecules, monoclonal antibodies are primarily cleared by the liver—an organ known for its radio-resistance. This characteristic, combined with the shortened half-life of RV-01 and the strong affinity for the target make this agent stand out and may offer a significant advantage not just over other monoclonal antibodies but also targeted radiotherapeutics with renal excretion pathway, the latter of which are often associated with higher risk of radiopharmaceutical-induced kidney toxicity,' noted Dimitris Voliotis, M.D., Chief Medical Officer of Radiopharm Theranostics. 'The high affinity and selectivity of RV-01 for the 4Ig isoform of B7H3 allows the antibody to bypass the soluble 2Ig isoform in the blood, boost binding of the radiopharmaceutical to tumor targets and avoid the formation of immune complexes in circulation,' noted David Piwnica-Worms, M.D., Ph.D., Professor, MD Anderson Cancer Center, and scientific co-founder of Radiopharm Ventures. B7-H3 is an immune checkpoint molecule that is overexpressed across several tumor types and has emerged as a compelling target for antibody-based cancer immunotherapy. Deregulated B7-H3 expression is consistently correlated with enhanced tumor aggressiveness and poor clinical outcomes. Targeting the 4 Ig isoform of B7-H3 with a selective radioligand therapy may offer a novel strategy for treating refractory or high-risk tumors. About RV-01 RV-01 is the first radiopharmaceutical therapeutic agent developed by Radiopharm Ventures, the Joint Venture formed between Radiopharm Theranostics and MD Anderson Cancer Center (MDACC). RV-01 is a 177Lutetium-conjugated therapeutic that targets B7-H3, an immune checkpoint molecule that is overexpressed in several tumor types. Multiple preclinical studies with RV-01 have shown tumor shrinkage and prolonged survival in animals treated with the radiotherapeutic agent. RV-01 has received IND-clearance from the U.S. FDA and plans to initiate a first-In-human Phase 1 study in the second half of 2025. About Radiopharm Theranostics Radiopharm Theranostics is a clinical stage radiotherapeutics company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. Radiopharm is listed on ASX (RAD) and on NASDAQ (RADX). The company has a pipeline of distinct and highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase 2 and three Phase 1 trials in a variety of solid tumor cancers including lung, breast, and brain. Learn more at Authorized on behalf of the Radiopharm Theranostics Board of Directors by Executive Chairman Paul Hopper. For more information: Investors:Riccardo CanevariCEO & Managing DirectorP: +1 862 309 0293E: rc@ Anne Marie FieldsPrecision AQ (formerly Stern IR)E: Media:Matt WrightNWR CommunicationsP: +61 451 896 420E: matt@ Follow Radiopharm Theranostics: Website – X – – –
Geek Tyrant
16 minutes ago
- Geek Tyrant
TERRESTRIAL Trailer Unveils a Mind-Bending Alien Thriller From HOT TUB TIME MACHINE Director Steve Pink — GeekTyrant
Steve Pink, best known for the outrageous comedy Hot Tub Time Machine , is venturing into mind-bending territory with his new sci-fi thriller Terrestrial . According to the official synopsis, 'The film centers around four college friends reuniting in Los Angeles at the beautiful and incredibly expensive mansion belonging to Allen (Fowler). Allen, a writer working on his first book, paints his life as a beautiful masterpiece, but cracks in the story begin to form. 'The discrepancies in his story and suspicious happenings around the house cause Allen's friends to question the stories he tells. As his story unravels, the three friends soon learn they are involved in something they never signed up for.' The trailer teases a surreal, paranoia-driven descent that flirts with sci-fi horror, psychological tension, and a dash of cosmic weirdness. The movie stars Jermaine Fowler ( Sorry to Bother You, Coming 2 America ), the ensemble cast also includes James Morosini ( It's What's Inside ), Pauline Chalamet ( The Sex Lives of College Girls ), Edy Modica ( Jury Duty ), Rob Yang ( Succession ), and Brendan Hunt ( Ted Lasso ). The script comes from Connor Diedrich and Samuel Johnson. Pink, who co-wrote classics like High Fidelity and Grosse Pointe Blank , appears to be channeling that sharp sense of character and dialogue into a very different sandbox. It looks like an eerie, psychedelic trip. The film will have its world premiere at the 29th Fantasia International Film Festival on July 20.
Yahoo
an hour ago
- Yahoo
‘The Fantastic Four: First Steps' Review: Marvel's Most Famous Family Trips Over Itself in MCU Debut
As might be inferred from its still-awkward subtitle, Matt Shakman's 'The Fantastic Four: First Steps' is a story about the mortal terror — and the profound thrill — of walking into the unknown. Here, in a movie that promises to push the Marvel Cinematic Universe out of its comfort zone before quickly retreating into a tired version of the same old schtick, only the terror shines through. It's the terror of a Hollywood film executive who's desperate to rejuvenate his sprawling mega-franchise, but deeply afraid of messing with the formula. It's also — for the best part of Shakman's film — the terror of a brilliant scientist who's dying to have a child with his wife, but petrified at the premise of an experiment that he doesn't have the power to control. More from IndieWire George Lucas Makes His First Ever Comic-Con Appearance A Casting Director Asked Steve Buscemi 'What Is Wrong with You?' in Massive Audition Fail While Fantastic Four leader Reed Richards can extend his limbs into any shape imaginable (a radiation-induced talent that 'First Steps' appears to forget about for appropriately long stretches of time), his sideburns turn grayer at the thought of living with his heart outside of his body. How do you rattle an invincible genius who can wiggle out of any problem with just a blackboard and some chalk? Give him a problem that no formula can solve. And that's exactly what 'First Steps' does with its opening act. The Fantastic Four have already established themselves as the most beloved family on Earth (well, their Earth) by the time we meet them — a shortcut that Josh Friedman, Jeff Kaplan, Eric Pearson, and Ian Springer's script will pay for down the road. Winsomely portrayed by Pedro Pascal as a worried egghead who's shelled inside his own thoughts, Reed may not be the most outspoken member of the superteam (that distinction belongs to Joseph Quinn's Johnny Storm, even if his flame is dulled to death in this film), but the fact that he's basically Tony Stark, Albert Einstein, and Bill Nye all rolled into one is still enough to make him the de facto frontman. Things are a bit shakier behind closed doors. When his wife reveals that she's pregnant after several years of trying and giving up, it's Reed who struggles to wrap his head around the known unknowns of what becoming a parent might entail. (Sue Storm is played by Vanessa Kirby, who finds any number of invisible nuances in a one-note part that largely reduces her to 'baby' in the same way that Ken's entire identity was 'beach.') Reed fights to make the retro-futuristic dimension of Earth-828 a place where it's safe for people to raise a child, but he understands his world too well to account for all of its variables; he can invent a teleportation device without breaking a sweat, but delegates the task of building a crib to his helper robot H.E.R.B.I.E. (whose 'Star Wars'-worthy design is somewhat wasted on beep-boop comic relief). In other words, Mister Fantastic is scared. As scared to have his first kid as Joel Miller was to lose his second one. And Pascal's performance is so raw and refreshing because the actor isn't afraid to lead with that fear. And for a while, the film around him isn't either. Indeed, the initial chapters of 'First Steps' are attuned to Reed's all too relatable neurosis in a way that makes it seem like the MCU is about to grow by leaps and bounds. Creating life in the face of an existential crisis requires a greater degree of magical thinking than Reed's brain was built to process, and when a naked metal Julia Garner surfs into Times Square and heralds the imminent arrival of the world-devouring space giant Galactus (Ralph Ineson), the news is like comeuppance for having the gall to bring something beautiful into a multiverse of gods and monsters. 'First Steps' might take place in a bizarro 1960s that's suspended between RKO and 'The Jetsons,' but its parental anxieties are ripped straight from our 21st century; Galactus' threat to 'Eat Reed's planet slowly while his son watches' is no different or more personal than what I hear every time a fascist opens their mouth on TV. Finally, it would seem, we're in for a Marvel movie with relatable human stakes. A Marvel movie in which a sequel doesn't feel like the only thing that's at risk. A Marvel movie in which saving the universe will require its characters to confront — and overcome — their mega-franchise's stultifying fear of change. Spoiler alert: We're not. 'First Steps' may have the good sense to sidestep — or at least speed through — the characters' hyper-familiar origin story, but it still feels like a movie we've seen 1,000 times before. In fairness, that movie has seldom looked this good. Superhero films thrive on a vivid sense of time and place, and Shakman's crew has an absolute field day with the mid-century modernism of Earth-828, every design choice of which radiates the modular optimism of a world that believes in itself. Imagine Don Draper trying to sell you a five-cent comic book: This New York City is the kind of place where anything's possible and life moves forward at the speed of a buoyant montage. Flying cars and nifty monorails zip between Bertrand Goldberg-inspired towers above ground, while Paul Walter Hauser's scene-stealing Mole Man rules over a subterranean paradise below. The skies are Pan-Am blue instead of CGI gray, and each living room comes with its own Lloyd fireplace. From its delightful props (e.g. a baby monitor shaped like an old tube TV) to its turtleneck costumes, 'First Steps' is the only MCU entry this side of 'Wakanda Forever' that feels like it actually wants to be looked at — not just watched. Alas, 'First Steps' loses its footing when it launches into space, loses the benefit of its scenery, and forces our attention on the plug-and-play jizz whizz at its core. The sky's the limit until the Fantastic Four leave Earth's atmosphere, at which point they immediately bump into the same low ceiling that makes all of the biggest Marvel movies feel like they have nowhere to grow. Galactus is quite a large boy, but the spectacle of his size — which Shakman can hardly contain in a single frame — isn't the only thing that makes the characters feel small. On the contrary, they shrink a bit more with every weightless action sequence and recycled joke, as the friction between Reed and Sue is subsumed into the stuff of garden variety special effects and 'that's all we get?' lore (Galactus wants to eat the Earth because he's very hungry, and the Silver Surfer is somehow even less nuanced). Absent the visual dynamism of Earth-828, we can't help but notice that Johnny was barely a character to begin with. Pivoting away from his legacy as a red-hot womanizer, the film tries to paint the Human Torch as a dilettante with something to prove, but it never really settles on what that something should be. (Making it appear as if Johnny is burning himself alive is just another one of the many things this movie is afraid of, and so it settles for a cartoonish fire effect that feels just a few degrees shy of the characters from 'Elemental.') His cool uncle schtick is shared with flaky rock creature Ben Grimm (Ebon Moss-Bachrach), who looks great, and brings a faint trace of upper-crust sophistication to a hero known for clobberin' anything that gets in his way, but leans way too hard on the vague loneliness that he sees in his own reflection. Ben is the strongest of the Fantastic Four, and yet even he struggles to carry the sort of smirking banter that hasn't been fresh since the first 'Avengers' (nothing suffocates the MCU like its sense of humor, which makes it all the more refreshing to see Hauser tunnel a new path towards the Mole Man's punchlines). Instead of an emotional arc, Ben has a crush on a Hebrew school teacher played by Natasha Lyonne; if only the sight of The Thing wearing a tallit were the strangest thing I've had to process as a Jew over the last few years. The Fantastic Four do eventually return to Earth-828 for the second half of the story, but at that point this film is so consumed by the usual song-and-dance — big stuff coming from above, the heroes have to zip around to stop it — that the fear of the unknown starts to feel less like a theme for 'First Steps' to to explore than an explanation for why it completely fails to do that. It doesn't help that Galactus is every bit as laughable as he is large (he was so much scarier and more compelling as a giant cloud in 2007's 'Fantastic Four: Rise of the Silver Surfer'), or that Shakman is too afraid of how silly his characters' superpowers look in live-action to have any fun with them, which is a problem 'The Incredibles' solved too well, and with too much comic ingenuity, for this movie to simply try and ignore. 'Family is about fighting for something bigger than yourself,' Sue insists. But as 'First Steps' limps to its total nothing of a conclusion, it feels less like a victory than it does a total surrender. You have to walk before you can run, but at this point the MCU is back to crawling on its knees, and at this point it seems like it might be too afraid to ever stand back up again. Grade: C Walt Disney Studios Motion Pictures will release 'The Fantastic Four: First Steps' in theaters on Friday, July 25. Want to stay up to date on IndieWire's film and critical thoughts? to our newly launched newsletter, In Review by David Ehrlich, in which our Chief Film Critic and Head Reviews Editor rounds up the best new reviews and streaming picks along with some exclusive musings — all only available to subscribers. Best of IndieWire The 25 Best Alfred Hitchcock Movies, Ranked Every IndieWire TV Review from 2020, Ranked by Grade from Best to Worst Solve the daily Crossword
